Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
Preprint in bioRxiv (May 2024)
The most recent citing publications are shown below. View all 98 publications that cite this research output on Dimensions.
Preprint in bioRxiv (May 2024)
Preprint in bioRxiv (March 2024)
Article in BMC Genomics (February 2024)